Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.
What Advanced files
- Others52
- Investor Meet40
- Updates19
- Board Meeting11
- Dividend/Bonus9
- PPTs9
Advanced Enzyme Technologies is acquiring the remaining 4.28% stake in its subsidiary, JC Biotech Private Limited (JCB), for a total consideration of ₹7.98 Cr. This strategic move will make JCB, a key manufacturer of bio-pharmaceuticals through aerobic fermentation with FY26 turnover of ₹72.8 Cr, a wholly-owned subsidiary. The acquisition aims...
Further to the intimation letter dated August 02, 2025, we hereby inform that the Companyhas completed an additional investment of ₹ 2.5 million in the wholly owned subsidiaryof the Company Advanced Nutrazyme Private Limited [ ANPL ] by way of investing inthe rights issue of 2,50,000 Equity Shares of ₹...
Advanced Enzyme Technologies is investing up to ₹1.62 Cr for a 26% equity stake in a new Special Purpose Vehicle (SPV) to establish a Group Captive Wind Power Plant. This strategic move aims to secure renewable energy for the company's operations, shifting focus from a previously planned solar project. The...
Advanced Enzyme Technologies (ADVENZYMES) has invested up to ₹1 Cr into Advanced Nutrazyme Private Limited, a newly incorporated wholly-owned subsidiary (formed July 4, 2025). This strategic capital infusion aims to boost sales and distribution channels specifically for ADVENZYMES' Nutrition & Wellness product range. The move reflects the company's commitment to...
Advanced Enzyme Technologies Limited's wholly owned subsidiary, Advanced Enzymes USA (AEU), has approved the formation of a new corporation, Starya Labs, Inc., in California. This entity will take over the enzyme/probiotic laboratory testing services from Cal-India Foods International USA, a step-down subsidiary, along with specific assets and liabilities valued at...